PATENT CLAIM ANALYSIS

Application Number: 16020875
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2020-01
Patent Classification: ["426", "655000"]

Abstract:
Embodiments herein relate to a concentrate of a kavalactone and methods for making the same, as well as products containing the concentrate, the concentrate comprising a noble kava comprising kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin, wherein the concentrate comprises 10% or more of the kavalactone as measured by HPLC.

Claim (Index 9):
The product of  claim 5 , wherein the selected part comprises the rhizome.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 94.0
- Lexical Diversity: 1.57895
- Patent Class: 426.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13163901', '10408900', '10263579', '10273943', '10273981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.765218480558793
- 35 USC 102 Novelty (BERT): 0.5261974181982609
- Combined Prediction Score: 0.7413163743227399
- Mean Citation Score: 262.251138
- Max Citation Score: 320.87875
- Similarity Product: 193.71985089443623

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test